{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:07:24Z","timestamp":1790719644410,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajgponline.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jagp.2025.02.016","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T19:22:10Z","timestamp":1741202530000},"page":"1184-1196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness of Clozapine Compared to Nonclozapine Antipsychotics in Older Adults With Schizophrenia in Brazil in a 16-Year Follow-Up"],"prefix":"10.1016","volume":"33","author":[{"given":"J\u00falio C\u00e9sar Menezes","family":"Vieira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna Afonso","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wallace Mateus","family":"Prata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helian Nunes","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Mariano","family":"Ruas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Augusto Afonso","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jagp.2025.02.016_bib0001","unstructured":"World Health Organization. Ageing and health. 1 october. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/ageing-and-health. 2022. Accessed January 3, 2024."},{"key":"10.1016\/j.jagp.2025.02.016_bib0002","unstructured":"IBGE - Instituto Brasileiro de Geografia e Estat\u00edstica. Censo: n\u00famero de idosos no Brasil cresceu 57,4% em 12 anos. 27\/10\/2023 11h58.https:\/\/agenciadenoticias.ibge.gov.br\/agencia-noticias\/2012-agencia-de-noticias\/noticias\/38186-censo-2022-numero-de-pessoas-com-65-anos-ou-mais-de-idade-cresceu-57-4-em-12-anos. 2023. Accessed January 3, 2024."},{"key":"10.1016\/j.jagp.2025.02.016_bib0003","unstructured":"World Health Organization. Mental health of older adults. Home\/newsroom\/fact sheets\/detail\/Mental health of older adults.https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/mental-health-of-older-adults. 2022. Accessed October 19, 2023."},{"key":"10.1016\/j.jagp.2025.02.016_bib0004","doi-asserted-by":"crossref","unstructured":"Rajji TK. Schizophrenia and cognition in late life. 2017:263-275. doi:10.1007\/978-981-10-2414-6_11","DOI":"10.1007\/978-981-10-2414-6_11"},{"issue":"4","key":"10.1016\/j.jagp.2025.02.016_bib0005","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1192\/bjp.bp.108.060723","article-title":"Age at onset and cognition in schizophrenia: Meta-analysis","volume":"195","author":"Rajji","year":"2009","journal-title":"British J Psychiatry"},{"issue":"3","key":"10.1016\/j.jagp.2025.02.016_bib0006","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jamapsychiatry.2015.2955","article-title":"Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: A network meta-analysis","volume":"73","author":"Samara","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"10.1016\/j.jagp.2025.02.016_bib0007","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1192\/bjp.bp.115.177261","article-title":"Clozapine v . first- and second-generation antipsychotics in treatment-refractory schizophrenia: Systematic review and meta-analysis","volume":"209","author":"Siskind","year":"2016","journal-title":"British J Psychiatry"},{"issue":"1","key":"10.1016\/j.jagp.2025.02.016_bib0008","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41398-021-01613-2","article-title":"Efficacy and safety of clozapine in psychotic disorders-a systematic quantitative meta-review","volume":"11","author":"Wagner","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"2","key":"10.1016\/j.jagp.2025.02.016_bib0009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4103\/jgmh.jgmh_2_24","article-title":"Clozapine in the elderly: Concerns and challenges","volume":"10","author":"Grover","year":"2023","journal-title":"J Geriatr Mental Health"},{"key":"10.1016\/j.jagp.2025.02.016_bib0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ajp.2018.03.008","article-title":"Clozapine use in geriatric patients\u2014 Challenges","volume":"33","author":"Mukku","year":"2018","journal-title":"Asian J Psychiatr"},{"key":"10.1016\/j.jagp.2025.02.016_bib0011","unstructured":"Brasil. Minist\u00e9rio da Sa\u00fade. Portaria no364, de 9 de abril de 2013. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas \u2013 Esquizofrenia. 2014. https:\/\/www.gov.br\/conitec\/pt-br\/midias\/protocolos\/pcdt-esquizofrenia-livro-2013-1.pdf. Accessed March 22, 2022."},{"issue":"5","key":"10.1016\/j.jagp.2025.02.016_bib0012","doi-asserted-by":"crossref","DOI":"10.1093\/ageing\/afab282","article-title":"Clinical trials in older people","volume":"51","author":"Pitkala","year":"2022","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.jagp.2025.02.016_bib0013","article-title":"Building the National database of Health centred on the individual: Administrative and epidemiological record linkage - Brazil, 2000-2015","volume":"3","author":"Junior","year":"2018","journal-title":"Int J Popul Data Sci"},{"key":"10.1016\/j.jagp.2025.02.016_bib0014","series-title":"Applied logistic regression","author":"Hosmer","year":"2013"},{"issue":"4","key":"10.1016\/j.jagp.2025.02.016_bib0015","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.jpsychires.2012.12.007","article-title":"The incidence and all-cause mortality of pneumonia in patients with schizophrenia: A nine-year follow-up study","volume":"47","author":"Chou","year":"2013","journal-title":"J Psychiatr Res"},{"issue":"12","key":"10.1016\/j.jagp.2025.02.016_bib0016","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1001\/jamapsychiatry.2015.1737","article-title":"Premature mortality among adults with schizophrenia in the United States","volume":"72","author":"Olfson","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.jagp.2025.02.016_bib0017","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/npr2.12034","article-title":"Risk factors for pneumonia in patients with schizophrenia","volume":"38","author":"Haga","year":"2018","journal-title":"Neuropsychopharmacol Rep"},{"key":"10.1016\/j.jagp.2025.02.016_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.746791","article-title":"Influencing factors of hospital-acquired pneumonia infection in the middle-aged and elderly patients with schizophrenia","volume":"12","author":"Yang","year":"2021","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.jagp.2025.02.016_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2022.114590","article-title":"Comparative risks of all-cause mortality for veterans with schizophrenia with ongoing receipt of clozapine and other antipsychotic medications","volume":"313","author":"Katz","year":"2022","journal-title":"Psychiatry Res"},{"issue":"9","key":"10.1016\/j.jagp.2025.02.016_bib0020","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.euroneuro.2016.07.006","article-title":"Comparative risk of death in older adults treated with antipsychotics: A population-based cohort study","volume":"26","author":"Schmedt","year":"2016","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.jagp.2025.02.016_bib0021","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1017\/S1041610214001756","article-title":"Effectiveness and safety of clozapine in elderly patients with chronic resistant schizophrenia","volume":"27","author":"Pridan","year":"2015","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jagp.2025.02.016_bib0022","doi-asserted-by":"crossref","unstructured":"Galletly C, Castle D, Dark F, et al. Royal Australian and New Zealand College of Psychiatrists Clinical Practice Guidelines for the management of schizophrenia and related disorders. Vol 50.; 2016. doi:10.1177\/0004867416641195","DOI":"10.1177\/0004867416641195"},{"key":"10.1016\/j.jagp.2025.02.016_bib0023","series-title":"Psychosis and Schizophrenia in Adults: Treatment and Management: Updated Edition 2014","year":"2014"},{"issue":"6","key":"10.1016\/j.jagp.2025.02.016_bib0024","doi-asserted-by":"crossref","first-page":"336","DOI":"10.9740\/mhc.2019.11.336","article-title":"Clozapine augmentation strategies","volume":"9","author":"Roerig","year":"2019","journal-title":"Mental Health Clin"},{"issue":"1","key":"10.1016\/j.jagp.2025.02.016_bib0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/acps.12742","article-title":"International trends in clozapine use: a study in 17 countries","volume":"136","author":"Bachmann","year":"2017","journal-title":"Acta Psychiatr Scand"},{"issue":"6","key":"10.1016\/j.jagp.2025.02.016_bib0026","first-page":"635","article-title":"Clozapine prescription trends in Brazil in the last decade","volume":"44","author":"Massuda","year":"2022","journal-title":"Brazil J Psychiatry"},{"issue":"April","key":"10.1016\/j.jagp.2025.02.016_bib0027","first-page":"1","article-title":"Clozapine prescription rates in Southeast Europe: A cross-sectional study","volume":"14","author":"Russo","year":"2023","journal-title":"Front Psychiatry"},{"issue":"1","key":"10.1016\/j.jagp.2025.02.016_bib0028","article-title":"Use of atypical antipsychotics in the treatment of schizophrenia in the Brazilian National Health System: a cohort study, 2008-2017","volume":"32","author":"Fulone","year":"2023","journal-title":"Epidemiologia e Servicos de Saude"},{"key":"10.1016\/j.jagp.2025.02.016_bib0029","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.schres.2018.02.035","article-title":"Cardio-metabolic risk and its management in a cohort of clozapine-treated outpatients","volume":"199","author":"Lappin","year":"2018","journal-title":"Schizophr Res"},{"issue":"2","key":"10.1016\/j.jagp.2025.02.016_bib0030","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1192\/bja.2021.24","article-title":"Setting up a clozapine service for Parkinson's psychosis","volume":"28","author":"Taylor","year":"2022","journal-title":"BJPsych Adv"},{"key":"10.1016\/j.jagp.2025.02.016_bib0031","doi-asserted-by":"crossref","DOI":"10.1017\/S1041610219000255","article-title":"Prescribing trends and safety of clozapine in an older persons mental health population","author":"Law","year":"2019","journal-title":"Int Psychogeriatr"},{"issue":"5","key":"10.1016\/j.jagp.2025.02.016_bib0032","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1517\/14740338.7.5.525","article-title":"The safety of clozapine in the elderly","volume":"7","author":"Gareri","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jagp.2025.02.016_bib0033","first-page":"1363","article-title":"Use of atypical antipsychotics in the elderly: A clinical review","volume":"9","author":"Gareri","year":"2014","journal-title":"Clin Interv Aging"},{"issue":"3","key":"10.1016\/j.jagp.2025.02.016_bib0034","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1192\/bja.2017.26","article-title":"Clozapine use in old age psychiatry","volume":"24","author":"Kirrane","year":"2018","journal-title":"BJPsych Adv"},{"issue":"10","key":"10.1016\/j.jagp.2025.02.016_bib0035","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/ijnp\/pyac036","article-title":"Clozapine treatment is associated with higher prescription rate of antipsychotic monotherapy and lower prescription rate of other concomitant psychotropics: A real-world nationwide study","volume":"25","author":"Ochi","year":"2022","journal-title":"Int J Neuropsychopharmacol"},{"issue":"3","key":"10.1016\/j.jagp.2025.02.016_bib0036","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/schbul\/sbu120","article-title":"The effect of clozapine on premature mortality: An assessment of clinical monitoring and other potential confounders","volume":"41","author":"Hayes","year":"2015","journal-title":"Schizophr Bull"},{"issue":"1","key":"10.1016\/j.jagp.2025.02.016_bib0037","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jcpt.12357","article-title":"Quetiapine safety in older adults: A systematic literature review","volume":"41","author":"El-Saifi","year":"2016","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"10.1016\/j.jagp.2025.02.016_bib0038","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1192\/bjp.bp.112.122499","article-title":"Comparative mortality risks of antipsychotic medications in community-dwelling older adults","volume":"205","author":"Gerhard","year":"2014","journal-title":"Br J Psychiatry"},{"issue":"10202","key":"10.1016\/j.jagp.2025.02.016_bib0039","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"The Lancet"},{"issue":"9690","key":"10.1016\/j.jagp.2025.02.016_bib0040","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(09)60742-X","article-title":"11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)","volume":"374","author":"Tiihonen","year":"2009","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.jagp.2025.02.016_bib0041","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006569.pub3","article-title":"Ziprasidone versus other atypical antipsychotics for schizophrenia","volume":"2009","author":"Komossa","year":"2009","journal-title":"Cochrane Datab System Rev"},{"issue":"9","key":"10.1016\/j.jagp.2025.02.016_bib0042","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00228-010-0839-9","article-title":"Prescription persistence and safety of antipsychotic medication: A national registry-based 3-year follow-up","volume":"66","author":"Gjerden","year":"2010","journal-title":"Eur J Clin Pharmacol"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748125000806?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748125000806?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T17:16:51Z","timestamp":1762363011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748125000806"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1064748125000806"],"URL":"https:\/\/doi.org\/10.1016\/j.jagp.2025.02.016","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of Clozapine Compared to Nonclozapine Antipsychotics in Older Adults With Schizophrenia in Brazil in a 16-Year Follow-Up","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Geriatric Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jagp.2025.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Association for Geriatric Psychiatry. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}